Stock comparison
Eli Lilly
LLY
Market cap
$946.37B
Sector
Healthcare
Overall winner
Eli Lilly
LLY 6–1 PODD
Insulet
PODD
Market cap
$10.31B
Sector
Healthcare
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
LLYvsPODD
65B
52C
76B
77B
75B
69B
64C
54C
68B
42D
75B
55C
66B
56C
Side-by-side metrics
| Metric | LLY | PODD |
|---|---|---|
| Market cap | $946.37B | $10.31B |
| P/E (TTM) | 35.6x | 34.4x |
| EV/EBIT | 33.2x | 22.7x |
| ROIC (TTM) | 32.06% | 16.39% |
| Gross margin | 83.51% | 71.01% |
| Net margin | 34.98% | 10.44% |
| Revenue CAGR 5y | 23.17% | 25.3% |
| EPS CAGR 5y | 40.81% | 93.57% |
| Debt / Equity | 1.4x | 0.7x |
| Dividend yield | 0.64% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
LLY leads on
- Dividend yield0.64%vs 0.0%+100%
- Market cap$946.37Bvs $10.31B+99%
- Net margin34.98%vs 10.44%+70%
- ROIC (TTM)32.06%vs 16.39%+49%
PODD leads on
- EPS CAGR 5y93.57%vs 40.81%+56%
- Debt / Equity0.7xvs 1.4x+48%
- EV/EBIT22.7xvs 33.2x+31%
- Revenue CAGR 5y25.3%vs 23.17%+8%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.